Cargando…
Real-world Evidence to Estimate Prostate Cancer Costs for First-line Treatment or Active Surveillance
BACKGROUND: Prostate cancer is the most common cancer in men and second leading cause of cancer-related deaths. Changes in screening guidelines, adoption of active surveillance (AS), and implementation of high-cost technologies have changed treatment costs. Traditional cost-effectiveness studies rel...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751921/ https://www.ncbi.nlm.nih.gov/pubmed/33367287 http://dx.doi.org/10.1016/j.euros.2020.11.004 |